Impact of shorter-acting neuromuscular blocking agents on fast-track recovery of the cardiac surgical patient

Keyphrases

• Pancuronium 100%
• Short-acting 100%
• Cardiac Surgical Patients 100%
• Neuromuscular Blocking Agents 100%
• Fast Track Recovery 100%
• Tracheal Extubation 80%
• Rocuronium 80%
• Intensive Care Unit 60%
• Muscle Relaxant 60%
• Cardiac Surgery 40%
• Cardiopulmonary Bypass 40%
• Intensive Care Unit Length of Stay 40%
• Ventilatory Support 40%
• Extubation Time 40%
• Muscle Weakness 20%
• Complete Data 20%
• Coronary Artery Bypass Grafting 20%
• Surgical Care 20%
• Length of Stay 20%
• Paresis 20%
• Anesthetics 20%
• Intensive Care Unit Management 20%
• Endotracheal Intubation 20%
• Maintenance Dose 20%
• Anesthetic Management 20%
• Valve Surgery 20%
• Delayed Recovery 20%
• Residual Paralysis 20%
• Recovery from Anesthesia 20%
• Tracheal Length 20%
• Single Valve 20%

Medicine and Dentistry

• Neuromuscular Blocking Agent 100%
• Intensive Care Unit 100%
• Pancuronium 83%
• Extubation 66%
• Rocuronium 66%
• Muscle Relaxant Agent 50%
• Cardiopulmonary Bypass 33%
• Heart Surgery 33%
• Tracheal Intubation 16%
• Paralysis 16%
• Paresis 16%
• Coronary Artery Bypass Graft 16%
• Muscle Weakness 16%
• Weakness 16%

Pharmacology, Toxicology and Pharmaceutical Science

• Neuromuscular Blocking Agent 100%
• Pancuronium 100%
• Rocuronium 80%
• Muscle Relaxant Agent 60%
• Muscle Weakness 20%
• Paralysis 20%
• Weakness 20%
• Intubation 20%
• Paresis 20%